Anaphylaxis in Medical Technology
Navigation Links
Anaphylaxis in Medical Technology
... treatment.
A severe allergic reaction called anaphylaxis has happened in some
patients after they received Xolair. anaphylaxis is a life-threatening
condition. Seek emergency ... away if symptoms occur.
Signs and symptoms of anaphylaxis include:
-- wheezing, shortness of breath, ...
... http://www.medimmune.com . Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe ...
... doses throughout the season. Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe ...
... hepatic failure, increases in serum creatinine in patients with renal insufficiency, acute hypersensitivity (angioedema, bronchoconstriction, anaphylaxis and cutaneous eruptions) and hypertriglyceridemia. During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years ...
... hepatic failure, increases in serum creatinine in patients with renal insufficiency, acute hypersensitivity (angioedema, bronchoconstriction, anaphylaxis and cutaneous eruptions) and hypertriglyceridemia. During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years ...
... hepatic failure, increases in serum creatinine in patients with renal insufficiency, acute hypersensitivity (angioedema, bronchoconstriction, anaphylaxis and cutaneous eruptions) and hypertriglyceridemia. During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years ...
... not indicated for dysfibrinogenemia. RiaSTAP is contraindicated in individuals who have had severe immediate hypersensitivity reactions, including anaphylaxis to RiaSTAP or its components. Physicians should monitor patients for early signs of allergic or hypersensitivity reactions and if necessary, ...
... limit of normal at 2 consecutive visits versus five (1.7%) patients treated with deferoxamine. Serious hypersensitivity reactions (such as anaphylaxis and angioedema) have been reported in patients receiving Exjade, with the onset of the reaction occurring in the majority of cases within the first ...
... joint damage. The most serious adverse reactions are systemic hypersensitivity reactions including bronchospastic reactions and/or hypotension and anaphylaxis and the development of high-titer inhibitors necessitating alternative treatments to AHF. The most common adverse reactions observed in clinical ...
... (28%), rash (25%), chest pain or tightness (24%), tachycardia (12%), dysphagia or laryngismus (5%), syncope (3%), allergic reaction (1%), or anaphylaxis (1%). These events were severe in 2% of patients. -- Death during infusion has been reported. Vascular Leak Syndrome -- This syndrome, ...
... one million children in the U.S. since its introduction in 1998. Very rare cases (<1 per 100,000 patients) of severe allergic reactions such as anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. These rare reactions may occur when any dose of Synagis ...
... among Native American infants at high risk for serious RSV disease. Very rare cases (<1 per 100,000 patients) of severe allergic reactions such as anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. These rare reactions may occur when any dose of Synagis ...
... infusions. Monitor patients for 1-hour following ERBITUX infusions in a setting with resuscitation equipment and other agents necessary to treat anaphylaxis (e.g., epinephrine, corticosteroids, intravenous antihistamines, bronchodilators, and oxygen). Longer observation periods may be required in patients ...
... infusions. Monitor patients for 1-hour following ERBITUX infusions in a setting with resuscitation equipment and other agents necessary to treat anaphylaxis (e.g., epinephrine, corticosteroids, intravenous antihistamines, bronchodilators, and oxygen). Longer observation periods may be required in patients ...
... throughout the season. Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe ...
... . Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) severe acute hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe ...
... /PRNewswire/ -- A new study suggests strong variation in the occurrence of anaphylaxis between the northern and southern U.S. anaphylaxis is a severe allergic reaction that can be fatal without treatment with ...
... should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information. About Berlex Berlex, ...
... for signs of hepatic injury. Routine periodic blood chemistry and hematology tests are recommended during treatment with AVONEX. Rare cases of anaphylaxis have been reported. Please see complete prescribing information available at www.AVONEX.com. About Biogen Idec Biogen Idec creates new standards ...
... should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information. About Bayer HealthCare ...
... should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information. About Bayer HealthCare ...
... rash (25%), chest pain or tightness (24%), tachycardia (12%), dysphagia or laryngismus (5%), syncope (3%), allergic reaction (1%) or anaphylaxis (1%). -- These events were severe in 2% of patients. Death during infusion has been reported. Vascular Leak Syndrome: -- ...
... http://www.medimmune.com . Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe ...
... doses throughout the season. Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe ...
... hepatic failure, increases in serum creatinine in patients with renal insufficiency, acute hypersensitivity (angioedema, bronchoconstriction, anaphylaxis and cutaneous eruptions) and hypertriglyceridemia. During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years ...
... hepatic failure, increases in serum creatinine in patients with renal insufficiency, acute hypersensitivity (angioedema, bronchoconstriction, anaphylaxis and cutaneous eruptions) and hypertriglyceridemia. During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years ...
... hepatic failure, increases in serum creatinine in patients with renal insufficiency, acute hypersensitivity (angioedema, bronchoconstriction, anaphylaxis and cutaneous eruptions) and hypertriglyceridemia. During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years ...
... not indicated for dysfibrinogenemia. RiaSTAP is contraindicated in individuals who have had severe immediate hypersensitivity reactions, including anaphylaxis to RiaSTAP or its components. Physicians should monitor patients for early signs of allergic or hypersensitivity reactions and if necessary, ...
... limit of normal at 2 consecutive visits versus five (1.7%) patients treated with deferoxamine. Serious hypersensitivity reactions (such as anaphylaxis and angioedema) have been reported in patients receiving Exjade, with the onset of the reaction occurring in the majority of cases within the first ...
... joint damage. The most serious adverse reactions are systemic hypersensitivity reactions including bronchospastic reactions and/or hypotension and anaphylaxis and the development of high-titer inhibitors necessitating alternative treatments to AHF. The most common adverse reactions observed in clinical ...
... (28%), rash (25%), chest pain or tightness (24%), tachycardia (12%), dysphagia or laryngismus (5%), syncope (3%), allergic reaction (1%), or anaphylaxis (1%). These events were severe in 2% of patients. -- Death during infusion has been reported. Vascular Leak Syndrome -- This syndrome, ...
... one million children in the U.S. since its introduction in 1998. Very rare cases (<1 per 100,000 patients) of severe allergic reactions such as anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. These rare reactions may occur when any dose of Synagis ...
... among Native American infants at high risk for serious RSV disease. Very rare cases (<1 per 100,000 patients) of severe allergic reactions such as anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. These rare reactions may occur when any dose of Synagis ...
... infusions. Monitor patients for 1-hour following ERBITUX infusions in a setting with resuscitation equipment and other agents necessary to treat anaphylaxis (e.g., epinephrine, corticosteroids, intravenous antihistamines, bronchodilators, and oxygen). Longer observation periods may be required in patients ...
Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease
... adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to Alpha-1 Proteinase Inhibitor products or their components and individuals with selective IgA deficiencies who have ...Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
... the risk for developing heparin-induced thrombocytopenia (with or without thrombosis), as well as protamine-associated side effects, such as anaphylaxis and systemic hypotension. About REG1 Anticoagulation System Regado's lead product candidate, REG1, is the first specific, direct-acting, ...Bayer Issues Additional Guidance to Physicians on Trasylol(R)
... bypass can be rapidly initiated. The benefit of Trasylol(R) to patients undergoing primary CABG surgery should be weighed against the risk of anaphylaxis associated with any subsequent exposure to aprotinin. (See CONTRAINDICATIONS, WARNINGS and PRECAUTIONS in the prescribing information.) Safety ...... infusions. Monitor patients for 1-hour following ERBITUX infusions in a setting with resuscitation equipment and other agents necessary to treat anaphylaxis (e.g., epinephrine, corticosteroids, intravenous antihistamines, bronchodilators, and oxygen). Longer observation periods may be required in patients ...
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
... bypass can be rapidly initiated. The benefit of Trasylol(R) to patients undergoing primary CABG surgery should be weighed against the risk of anaphylaxis associated with any subsequent exposure to aprotinin. (See CONTRAINDICATIONS, WARNINGS and PRECAUTIONS in the prescribing ...... throughout the season. Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe ...
... . Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) severe acute hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe ...
... /PRNewswire/ -- A new study suggests strong variation in the occurrence of anaphylaxis between the northern and southern U.S. anaphylaxis is a severe allergic reaction that can be fatal without treatment with ...
... should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information. About Berlex Berlex, ...
... for signs of hepatic injury. Routine periodic blood chemistry and hematology tests are recommended during treatment with AVONEX. Rare cases of anaphylaxis have been reported. Please see complete prescribing information available at www.AVONEX.com. About Biogen Idec Biogen Idec creates new standards ...
... should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information. About Bayer HealthCare ...
... should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information. About Bayer HealthCare ...
... rash (25%), chest pain or tightness (24%), tachycardia (12%), dysphagia or laryngismus (5%), syncope (3%), allergic reaction (1%) or anaphylaxis (1%). -- These events were severe in 2% of patients. Death during infusion has been reported. Vascular Leak Syndrome: -- ...
First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
... issue of the Journal of Immunology. This research was supported in part by grants from the National Institutes of Health and the Food Allergy and anaphylaxis Network. A copy of the study is available to reporters in PDF format by email request from the American Association of Immunologists at ...Other ContentsphloembilayerbilayerlipidlipidlipidlipidlipidlipidlipidlipidlipidphosphorylationphosphorylationphosphorylationphosphorylationphosphorylationphosphorylationphotonphotonphotonphotonphotonreactionreactionreactionreactionreactionreactionreactionreactionreactiondependentdependentdependentdependentdependentdependentdependentdependentdependentOther TagscounterfeitsellingprintprintprintprintprintCIOssellsellsell
(Date:12/5/2009)... exhaustive research into venom produced by snakes and spiders, ... a mystery. Now, a study of 158 catfish species, ... Biology , has catalogued the presence of venom glands ... Wright, from the University of Michigan, USA, carried out ... techniques to elucidate the diversity and distribution of venomous ...
(Date:12/4/2009)... the Royal Botanic Gardens, Kew and the Natural History ... more widespread than previously thought, with many commonly grown ... way to being "meat eaters". A review paper, Murderous ... carnivory, is published today (4 December 2009) in the ...
(Date:12/3/2009)... BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... biometric identification solutions, announced that a majority of ... today approved the sale of the company,s Law ... the shares voted, 98.6% were cast in favor ...
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 1The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 2PSE 26G Childrens Specialized Hospital and New York Giants Team Up to Offer Text to Donate Campaign 56867 1PSE 26G Childrens Specialized Hospital and New York Giants Team Up to Offer Text to Donate Campaign 56867 2UnisourceDirect 26amp 3B 238482 3B Web Site Now Offering Products to Maintain a Healthy School Environment 56865 1UnisourceDirect 26amp 3B 238482 3B Web Site Now Offering Products to Maintain a Healthy School Environment 56865 2UnisourceDirect 26amp 3B 238482 3B Web Site Now Offering Products to Maintain a Healthy School Environment 56865 3(Date:12/5/2009)... wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay ... 40th birthday without ever tying the knot, since research has ... folks. And, um, isn,t there something wrong with those who ... new study looking at psychological measures shows that never-married people ...
(Date:12/5/2009)... most unusual places, and to do everything from growing mushrooms, making wine ... ... Who would have thought that your wine, water and vegetables would have ... a new line of turbines, for industry end users, not wind farms. ...
(Date:12/4/2009)... FRANCISCO, Dec. 4 Medithrive, Inc. has won the ... SF Bay Area by popular vote conducted by the ... in operation, the SF Bay community has selected Medithrive ... ,, The rapid rise and popularity of Medithrive ...
(Date:12/4/2009)... two-day free health clinic sponsored by the National Association of ... is not just for the sick but also for anyone ... All participants in the health clinic will receive preventive primary ... large free clinic events this fall in Houston, New Orleans ...
(Date:12/4/2009)... Dec. 4 In response to the ... classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as ... (CSA), John Gay, executive director and CEO ... oldest and largest trade association representing ...
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2[0] Never Married, Over 40, Well-Adjusted[0] Distributor Announces New Applications for Wind Turbines [0] Medithrive Voted #1 Medicinal Marijuana Dispensary in Bay Area[0] Free Health Clinic Event Is Not Just for the Sick[0] Natural Products Association Issues Statement on DEA's Steroid Classification Action
ButlereBaycounterfeitsellingconvictedleveragingadvisorsimaginationsprintCIOsretailingpetroleumsizzlingsell
Other Tagsscreenings 2screenings 3daughter 2daughter 3daughter 4daughter 5daughter 6daughter 7daughter 8daughter 9fitted 2fitted 3fitted 4pharmaceutical 2pharmaceutical 3pharmaceutical 4pharmaceutical 5pharmaceutical 6pharmaceutical 7pharmaceutical 8paves 2synthesis 2synthesis 3synthesis 4synthesis 5synthesis 6synthesis 7synthesis 8guide 2guide 3guide 4guide 5guide 6guide 7delivery 2delivery 3delivery 4delivery 5delivery 6delivery 7delivery 8delivery 9delivery 10| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |